Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 15/12/2019
SIETES contiene 92855 citas

 
 
 1 a 20 de 57 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Chang HY, Singh S, Mansour O, Baksh S, Alexander GC. Association between sodium-glucose cotransporter 2 inhibitors and lower extremity amputation among patients with type 2 diabetes. JAMA Intern Med 2018:13 de agosto. [Ref.ID 102824]
2. Cita con resumen
Jull A, Wadham A, Bullen C, Parag V, Kerse N, Waters J. Low dose aspirin as adjuvant treatment for venous leg ulceration: pragmatic, randomised, double blind, placebo controlled trial (Aspirin4VLU). BMJ 2017;359:j5157. [Ref.ID 102158]
4.
Augustin M, Vanscheidt W. Chronic venous leg ulcers: the future of cell-based therapies. Lancet 2012;380:953-5. [Ref.ID 93762]
5.
Nogaro M-C, Pournaras DJ, Prasannan C, Chaudhuri A. Varicose veins. BMJ 2012;344:45-6. [Ref.ID 92384]
6.
van Gent WB, Wilschut ED, Wittens C. Management of venous ulcer disease. BMJ 2010;341:1092-6. [Ref.ID 89699]
8.Tiene citas relacionadas
Soares MO, Iglesias CP, Bland JM, Cullum N, Dumville JC, Nelson EA, Torgerson DJ, Worthy G, on behalf of the VenUS II team. Cost effectiveness analysis of larval therapy for leg ulcers. BMJ 2009;338:1050-4. [Ref.ID 85739]
9.Tiene citas relacionadas
Dumville JC, Worthy G, Bland JM, Cullum N, Dowson C, Iglesias C, Mitchell JL, Nelson EA, Soares MO, Torgerson DJ, on behalf of the VenUS II team. Larval therapy for leg ulcers (VenUS II): randomised controlled trial. BMJ 2009;338:1047-50. [Ref.ID 85738]
10.Tiene citas relacionadas
Grey JE, Leaper D, Harding K. How to measure success in treating chronic leg ulcers. BMJ 2009;338:1021-2. [Ref.ID 85733]
11. Cita con resumen
Anónimo. Drugs and cancer risk. JAMA 2008;300:386. [Ref.ID 83707]
12. Cita con resumen
Anónimo. Bécaplermine topique: cancers. Prescrire 2008;28:430. [Ref.ID 83097]
13.
Palfreyman S, Nelson EA, Michaels JA. Dressings for venous leg ulcers: systematic review and meta-analysis. BMJ 2007;335:244-8. [Ref.ID 80752]
14.Tiene citas relacionadas Cita con resumen
Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment for diabetic foot ulcers. Lancet 2005;366:1725-35. [Ref.ID 75465]
15. Cita con resumen
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005;293:217-28. [Ref.ID 72495]
16.
Boulton AJM, Kirsner RS, Vileikyte L. Neuropathic diabetic foot ulcers. N Engl J Med 2004;351:48-55. [Ref.ID 70528]
17.Tiene citas relacionadas
Thomas DR. The promise of topical growth factors in healing pressure ulcers. Ann Intern Med 2003;139:694-5. [Ref.ID 67909]
18.Tiene citas relacionadas Cita con resumen
Landi F, Aloe L, Russo A, Cesari M, Onder G, Bonini S, Carbonin PU, Bernabei R. Topical treatment of pressure ulcers with nerve growth factor. A randomized clinical trial. Ann Intern Med 2003;139:635-41. [Ref.ID 67905]
19. Cita con resumen
Jeffcoate W, Harding KG. Diabetic foot ulcers. Lancet 2003;361:1445-551. [Ref.ID 65993]
20.
de Araujo T, Valencia I, Federman DG, Kirsner RS. Managing the patient with venous ulcers. Ann Intern Med 2003;138:326-34. [Ref.ID 65433]
Seleccionar todas
 
 1 a 20 de 57 siguiente >>